MEP38808A - Use of lh in controlled ovarian hyperstimulation - Google Patents

Use of lh in controlled ovarian hyperstimulation

Info

Publication number: MEP38808A
Authority: ME; Montenegro
Prior art keywords: ovarian hyperstimulation; controlled ovarian; coh; controlled; folliculogenesis
Prior art date: 2001-09-12

Application number

MEP-388/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Stephen Hillier

Colin Michael Howles

Original Assignee

Merck Serono Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-12

Filing date

2002-09-12

Publication date

2011-02-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP38808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-09-12 Application filed by Merck Serono Sa filed Critical Merck Serono Sa

2011-02-10 Publication of MEP38808A publication Critical patent/MEP38808A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

MEP-388/08A 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation MEP38808A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01307755		2001-09-12
PCT/GB2002/004147 WO2003022301A2 (en)	2001-09-12	2002-09-12	Use of lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number	Publication Date
MEP38808A true MEP38808A (en)	2011-02-10

Family

ID=8182260

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-388/08A MEP38808A (en)	2001-09-12	2002-09-12	Use of lh in controlled ovarian hyperstimulation

Country Status (27)

Country	Link
US (1)	US7341989B2 (es)
EP (1)	EP1434600B1 (es)
JP (1)	JP2005504072A (es)
KR (1)	KR20040032953A (es)
CN (1)	CN1302806C (es)
AR (1)	AR036591A1 (es)
AT (1)	ATE427755T1 (es)
AU (1)	AU2002331939B2 (es)
BR (1)	BR0212502A (es)
CA (1)	CA2457067A1 (es)
CY (1)	CY1110487T1 (es)
DE (1)	DE60231892D1 (es)
DK (1)	DK1434600T3 (es)
EA (1)	EA009210B1 (es)
ES (1)	ES2322136T3 (es)
HR (1)	HRP20040070A2 (es)
IL (1)	IL160781A0 (es)
ME (1)	MEP38808A (es)
MX (1)	MXPA04002125A (es)
NO (1)	NO327154B1 (es)
PL (1)	PL205472B1 (es)
PT (1)	PT1434600E (es)
RS (1)	RS51505B (es)
SI (1)	SI1434600T1 (es)
UA (1)	UA78970C2 (es)
WO (1)	WO2003022301A2 (es)
ZA (1)	ZA200401008B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005530818A (ja) *	2002-06-07	2005-10-13	アレストレーディングソシエテアノニム	卵巣過剰刺激の制御方法及び当該方法に利用する医薬キット
US20040248784A1 (en) *	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
CN102296047B (zh) *	2011-08-13	2013-03-13	新疆农垦科学院	利用羔羊超排卵母细胞生产体外胚胎的方法
US9216037B2 (en)	2013-06-21	2015-12-22	Previvo Genetics, Llc	Uterine lavage for embryo retrieval
US20150272622A1 (en)	2011-12-22	2015-10-01	Previvo Genetics, Llc	Recovery and processing of human embryos formed in vivo
US9282995B2 (en) *	2011-12-22	2016-03-15	Previvo Genetics, Llc	Recovery and processing of human embryos formed in vivo
EP2968391A1 (en)	2013-03-13	2016-01-20	Moderna Therapeutics, Inc.	Long-lived polynucleotide molecules
RU2629871C1 (ru) *	2016-03-22	2017-09-04	Сергей Михайлович Юдин	Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) *	2020-09-18	2022-03-18	Marca Antonio La	Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4589402A (en)	1984-07-26	1986-05-20	Serono Laboratories, Inc.	Method of in vitro fertilization
IT1250075B (it) *	1991-12-18	1995-03-30	Serono Cesare Ist Ricerca	Composizioni farmaceutiche contenenti gonadotropine.
DK1176976T4 (en)	1999-05-07	2015-11-02	Serono Lab	Use of LH administered mid- or senfollikelfase for the treatment of anovulatory women

2002
- 2002-09-12 ES ES02767637T patent/ES2322136T3/es not_active Expired - Lifetime
- 2002-09-12 JP JP2003526429A patent/JP2005504072A/ja active Pending
- 2002-09-12 MX MXPA04002125A patent/MXPA04002125A/es active IP Right Grant
- 2002-09-12 WO PCT/GB2002/004147 patent/WO2003022301A2/en not_active Ceased
- 2002-09-12 CN CNB028175743A patent/CN1302806C/zh not_active Expired - Fee Related
- 2002-09-12 CA CA002457067A patent/CA2457067A1/en not_active Withdrawn
- 2002-09-12 BR BR0212502-1A patent/BR0212502A/pt not_active Application Discontinuation
- 2002-09-12 IL IL16078102A patent/IL160781A0/xx unknown
- 2002-09-12 AT AT02767637T patent/ATE427755T1/de active
- 2002-09-12 AR ARP020103455A patent/AR036591A1/es not_active Application Discontinuation
- 2002-09-12 AU AU2002331939A patent/AU2002331939B2/en not_active Ceased
- 2002-09-12 US US10/487,423 patent/US7341989B2/en not_active Expired - Fee Related
- 2002-09-12 HR HR20040070A patent/HRP20040070A2/hr not_active Application Discontinuation
- 2002-09-12 EP EP02767637A patent/EP1434600B1/en not_active Revoked
- 2002-09-12 PL PL367343A patent/PL205472B1/pl unknown
- 2002-09-12 RS YUP-212/04A patent/RS51505B/sr unknown
- 2002-09-12 ME MEP-388/08A patent/MEP38808A/xx unknown
- 2002-09-12 DE DE60231892T patent/DE60231892D1/de not_active Expired - Lifetime
- 2002-09-12 KR KR10-2004-7002589A patent/KR20040032953A/ko not_active Ceased
- 2002-09-12 EA EA200400428A patent/EA009210B1/ru not_active IP Right Cessation
- 2002-09-12 SI SI200230815T patent/SI1434600T1/sl unknown
- 2002-09-12 DK DK02767637T patent/DK1434600T3/da active
- 2002-09-12 PT PT02767637T patent/PT1434600E/pt unknown
- 2002-12-09 UA UA2004031858A patent/UA78970C2/uk unknown
2004
- 2004-02-06 ZA ZA2004/01008A patent/ZA200401008B/en unknown
- 2004-03-08 NO NO20040990A patent/NO327154B1/no not_active IP Right Cessation
2009
- 2009-06-30 CY CY20091100694T patent/CY1110487T1/el unknown

Also Published As

Publication number	Publication date
HRP20040070A2 (en)	2004-10-31
SI1434600T1 (sl)	2009-06-30
DK1434600T3 (da)	2009-05-25
WO2003022301A2 (en)	2003-03-20
IL160781A0 (en)	2004-08-31
CA2457067A1 (en)	2003-03-20
DE60231892D1 (de)	2009-05-20
NO327154B1 (no)	2009-05-04
PT1434600E (pt)	2009-04-28
EP1434600B1 (en)	2009-04-08
CY1110487T1 (el)	2015-04-29
RS51505B (sr)	2011-06-30
WO2003022301A3 (en)	2003-04-17
AU2002331939B2 (en)	2007-10-25
KR20040032953A (ko)	2004-04-17
EA200400428A1 (ru)	2004-08-26
JP2005504072A (ja)	2005-02-10
MXPA04002125A (es)	2004-07-08
US20050049199A1 (en)	2005-03-03
AR036591A1 (es)	2004-09-22
ATE427755T1 (de)	2009-04-15
PL205472B1 (pl)	2010-04-30
ZA200401008B (en)	2005-08-31
CN1302806C (zh)	2007-03-07
EA009210B1 (ru)	2007-12-28
YU21204A (sh)	2006-08-17
EP1434600A2 (en)	2004-07-07
US7341989B2 (en)	2008-03-11
NO20040990L (no)	2004-03-08
UA78970C2 (uk)	2007-05-10
HK1067866A1 (en)	2005-04-22
PL367343A1 (en)	2005-02-21
CN1553809A (zh)	2004-12-08
ES2322136T3 (es)	2009-06-17
BR0212502A (pt)	2004-08-24

Similar Documents

Publication	Publication Date	Title
UA42747C2 (uk)	2001-11-15	Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
MEP38808A (en)	2011-02-10	Use of lh in controlled ovarian hyperstimulation
BR9106702A (pt)	1993-06-08	Analogo de oligonucleotideos e processos para modular a producao de uma proteina por um organismo e para tratar um organismo
BR9006729A (pt)	1991-08-06	Dispositivo de reforco e de sustentacao da capa dos rotadores de uma articulacao de ombro humano
HUP0003349A2 (hu)	2001-01-29	Mellékpajzsmirigy-hormon peptidanalógok, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
DE69839812D1 (de)	2008-09-11	Analoge des menschlichen interferon-alpha mit niedriger toxizität
DE69930758D1 (de)	2006-05-18	Verwendung von daptomycin
NO952744D0 (no)	1995-07-11	Cytokinbegrensende midler
BR9906796A (pt)	2000-11-14	Método para a administração de análogos de insulina monoméricos
DE69033521D1 (de)	2000-05-31	Verwendung von arginin als immunstimulator
KR950031060A (ko)	1995-12-18	골다공증 치료용 약제학적 조성물
DK1473040T3 (da)	2010-03-15	Anvendelse af humant parathyroidhormon
DE69814109D1 (de)	2003-06-05	1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
EA200801714A1 (ru)	2008-12-30	Нетоксичные для нервной ткани плазминоген-активирующие факторы для лечения инсульта
ES2135398T3 (es)	1999-11-01	Compuesto y composiciones de inhibicion de la resorcion osea.
DK0678013T3 (da)	1997-05-26	Præparater til behandling af hår
DE69630583D1 (de)	2003-12-11	Peptide, bronchodilator und den blutstrom verbesserndes mittel
ES2108122T3 (es)	1997-12-16	Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
ATE398134T1 (de)	2008-07-15	Neue analoga von nitrobenzylthioinosin
ATE433749T1 (de)	2009-07-15	Neue verwendung von rapamycin und strukturellen analoga hiervon
KR950013519A (ko)	1995-06-15	골절 예방 및 치료용 약제
ATE374202T1 (de)	2007-10-15	Neue analoga von nitrobenzylthioinosin
DK1007085T3 (da)	2002-05-13	Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
EA201000501A1 (ru)	2010-10-29	Фармацевтическая композиция, содержащая не обладающий нейротоксичностью активатор плазминоген для лечения удара
YU169090A (sh)	1993-10-20	Tetra hidroimidazo (1,4) benzodiazepini